Metformin Hydrochloride
Pricing Report NDC 0591-2719-60

Current NADAC: $0.16440 per EA · Effective Sep 23, 2026 · Est. package price $9.86 (60 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The current wholesale acquisition cost for Metformin Hydrochloride (NDC 0591-2719-60) is $0.16440 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 23, 2026.

As a provided by Actavis Pharma, Inc., this medication is distributed in a 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.16440
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Sep 23, 2026
Billable Units
60 EA
Estimated Package Price
$9.86
Data Status
As of Oct 07, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
0591-2719-60
Description
60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.10169 to $7.27513 per EA. Over this 13 years and 2 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.1017 - $7.2751
Market Volatility
7,054.22% Variance
Latest Trend
18.85%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 23, 2026 $0.16440 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 19, 2026 $0.13832 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 22, 2026 $0.11636 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 17, 2026 $0.11081 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 20, 2026 $0.10529 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 22, 2026 $0.10169 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 18, 2026 $0.10577 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 18, 2026 $0.11154 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 21, 2026 $0.11801 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 17, 2025 $0.12739 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 19, 2025 $0.15413 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 22, 2025 $0.17224 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026